Events Partner Content Gut-Brain Axis 2018 On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year's ev
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.